Old drug, new trick: can spironolactone silence HIV?

NCT ID NCT07415811

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small, early study is testing whether spironolactone, a drug already approved for high blood pressure, can reduce the hidden HIV reservoir in people on effective HIV treatment. Researchers will give the drug to 12 adults (both with and without HIV) to see how it affects a key protein and how the body processes it. The goal is to gather initial safety and biological data to see if spironolactone could one day be part of an HIV cure strategy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bites and Stings HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Grupo de Pesquisa Clínica em Moléstias Infecciosas

    São Paulo, São Paulo, 05401000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.